These medications work by influencing appetite regulation and metabolic pathways
Diabetes and related NDs share common mechanisms, such as central IR, oxidative stress, and inflammation, which underlie their crosstalk, which has also inspired the investigation of hypoglycemic agents, particularly GLP-1 RA, as potential treatments for diabetes and related NDs
10.1016/j.euroneuro.2021.11.009 306 MalhiG
Weight Loss Timeline: When You'll See Results on the Scale Meaningful weight loss generally emerges between weeks 2 and 4 of treatment as semaglutide accumulates and your eating patterns shift
Safety Profile Cagrilintide has been studied in multiple Phase 2 and Phase 3 trials involving thousands of participants
It is essential to know more before starting dosages